PhaseBio Pharmaceuticals Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Malvern, PA
SEC filing record 1 source field available
Fiscal year end
31 December
PhaseBio Pharmaceuticals Inc has filed 371 SEC EDGAR filings since 25 Feb 2002

SEC filing history

Showing 26-50 of 364 matching filings.

Per page
25
Current page
2
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-38697

NT 10-Q

Filing date
16 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-38697

NT 10-K

Filing date
03 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90691

SEC SCHEDULE 13G

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-38697

25-NSE filing

Filing date
21 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-38697

NT 10-Q

Filing date
15 Nov 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90691

NEW ENTERPRISE ASSOCIATES 13, LP (PHASEBIO PHARMACEUTICALS) - SCHEDULE 13D/A#1E

Filing date
04 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Oct 2022
Reporting date
25 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .